[1]
A. D. MENEZES and N. A. FRAIJI, “Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil”, Rev Bras Farm Hosp Serv Saude, vol. 11, no. 4, p. 510, Nov. 2020.